Clinical data from 15 DM patients and 8 non‐DM controls revealed inverse correlations between ALKBH5 expression and cardiac injury markers (BNP, cTnl), suggesting ALKBH5 levels could serve as a diagnostic indicator for DICM severity. Here, ALKBH5 is linked to diabetes mellitus.